Please login to the form below
YouTube
This page shows the latest YouTube news and features for those working in and with pharma, biotech and healthcare.
FDA experts to evaluate Pfizer-BioNTech COVID-19 booster
The expert panel session will also be public, livestreamed on the FDA’s YouTube channel, offering what the Washington Post calls “much-needed clarity and transparency to a decision-making process
Latest news
-
Making social sexy
on YouTube, and a mere 1.2 million using Instagram.
-
Will your clinical trial blend?
As if the latest object might finally prove to be the Blendtec’s undoing, he starts each of the 187 videos on his YouTube channel with the same tantalising question: ‘Will
-
Chaperone Leadership
YouTube. A big, central finding was that, in our business, two of the commonly held models of leadership don’t really hold true.
-
Current and future trends for developing digital medical communications
This is driving the development of products such as multi- format, SCORM-compliant e-learning and training platforms with meaningful metrics, as well as multichannel-optimised YouTube channels as essential offerings
-
Q&A: Mike Dixon
Apologies to millennial readers, this answer may not make any sense to you unless you watch old children’s cartoons on YouTube!).
Making social sexy
Will your clinical trial blend?
Chaperone Leadership
Current and future trends for developing digital medical communications
Q&A: Mike Dixon
More from news
Approximately 12 fully matching, plus 156 partially matching documents found.
Latest Intelligence
-
Will biosimilars ever catch on in the US?
Additionally, a YouTube video sponsored by Amgen questioned the safety of biosimilars.
-
Can marketing change the world?
For example, last summer, Anjali Sud, CEO of Vimeo, described how the tech company had worked with its biggest competitor, YouTube, to overcome a customer pain point around publishing videos across ... What we ended up doing was actually building a
-
Case study: Tackle TD for Bayer UK
seeded out at intervals throughout the year to a highly targeted audience via paid media on the Bayer Facebook and YouTube channels.
-
We’ll need more than a spoonful of sugar to counter vaccine hesitancy
Instagram will not show or recommend content with misinformation about vaccinations in Instagram’s Explore, hashtag and search pages, while YouTube has removed the ability to advertise anti-vaccination content.
-
What pharma marketers can learn from Disney
Channels such as YouTube, while immensely popular among both HCPs and patients, are considered off-limits by many companies, while patient advocacy groups capitalise on them for disease awareness.
Will biosimilars ever catch on in the US?
Can marketing change the world?
Case study: Tackle TD for Bayer UK
We’ll need more than a spoonful of sugar to counter vaccine hesitancy
More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.
Latest appointments
-
McCann Health London bolsters creative leadership team
Before joining the London team, he worked on the launch of national and international campaigns, including a meningitis awareness campaign that has almost 50 million views on YouTube.
McCann Health London bolsters creative leadership team
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Tyson Fury takes on his Invisible Opponent in hard hitting ad for suicide prevention charity Campaign Against Living Miserably
The campaign, planned by the7stars, will be backed up by VOD and YouTube, as well as JCDecaux UK’s Transvision screens nationwide.
-
Numbers, navigation, and narratives: digital storytelling in medical communications
Watching YouTube videos is the new way of storytelling and sharing, but we engage with these videos because of the content the YouTuber creates, not because we’re excited by the
-
A personal perspective on autism
He has his own YouTube channel and is very popular with his peers. ... His IT skills are good and he can edit videos in YouTube.
-
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences
-
Top 10 Tips for Creating Company Culture in a Virtual World
In fact, I have previously explored this topic as part of our Courageous Conversations series, available on YouTube and as a podcast.
Tyson Fury takes on his Invisible Opponent in hard hitting ad for suicide prevention charity Campaign Against Living Miserably
More from PMHub
Approximately 3 fully matching, plus 30 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- bluebird bio gears up for split
- EU identifies first five ‘promising’ COVID-19 drugs as part of therapeutics strategy
- Nicky Hutchens appointed as deputy managing director at Four Health
- Health For All
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
- Accelerating Drug Development Timelines with Big Data Analytics
- A Lucid Group Thirsty Thursday Special: Beautiful Rejects
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Lilly to target difficult-to-treat disease through tie-up with Lycia
- Sanofi/Regeneron bag first approval for Actemra rival sarilumab
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
